General Information
Version
1.01
Revision date
2025-12-09
Product name
tranexamic acid
Substance name
Tranexamic Acid
CAS No.
1197-18-8
1.2.1 Relevant identified uses
Laboratory use
supplier name
British Pharmacopoeia Commission
Emergency telephone
+44 (0)20 3080 6561
Icons in SDS
Company Information
company name
British Pharmacopoeia Commission
e-mail address of the competent person responsible for the Safety Data Sheet
bpcrs@mhra.gov.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H335, H336, H362
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
Contains
Tranexamic acid
Signal word
Warning
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation. H336 - May cause drowsiness or dizziness. H362 - May cause harm to breast-fed children.
Precautionary statements
P201 - Obtain special instructions before use P260 - Do not breathe dust, fume, gas, mist, vapors and spray P263 - Avoid contact during pregnancy and while nursing P264 - Wash face, hands and any exposed skin thoroughly after handling P280 - Wear protective gloves, eye protection and face protection P321 - Specific treatment (see supplemental first aid instructions on this label) P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P337 + P313 - If eye irritation persists: Get medical advice/attention
2.3 Other hazards
No information available.
PBT Substances
& vPvB This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin irritation Category 2 - (H315) Eye irritation Category 2 - (H319) Skin sensitisation Category 1 - (H317) Effects on or via lactation Yes - (H362) Specific target organ toxicity (single exposure) Category 3 - (H335, H336) Category 3 Target organ effects: Respiratory irritation, Narcotic effects.
